Global Neurology Academy

The Global Neurology Academy (GNA) series offers certified education modules and video interviews from leading MS experts from across the globe as they address topics such as induction therapy in relapsing-remitting multiple sclerosis; No Evidence of Disease Activity (NEDA) concept; how different agents used in MS management may be utilized in induction therapy; appreciation of how reductions in end-organ damage impact patient quality-of-life; mechanisms of action of the classical as well as emergent agents; key issues associated with making the correct differential diagnosis of multiple sclerosis, in addition to how best to incorporate prognostic indicators into clinical decision-making; current and emergent novel oral agents in MS management; and diagnostic strategies and identifying predictors of outcome.

For more information about GNA, visit www.globalneurologyacademy.org.

406

LikeLikedUnlike

1-15 of 233

CME/CE Virtual Event
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
Multiple dates available
1.00 credits
Treating ADHD in the Presence of Comorbidities
NeuroFrontiers
Treating ADHD in the Presence of Comorbidities
- Roberto Olivardia, PhD
Sleep and ADHD: Breaking the Cycle
NeuroFrontiers
Sleep and ADHD: Breaking the Cycle
- Roberto Olivardia, PhD
Long-Term ADHD Treatment: Examining Stimulant Tolerance
NeuroFrontiers
Long-Term ADHD Treatment: Examining Stimulant Tolerance
- James Swanson, PhD
Supporting Students with ADHD and Learning Differences
NeuroFrontiers
Supporting Students with ADHD and Learning Differences
- Roberto Olivardia, PhD
Tracking ADHD Over Time in the MTA Study
NeuroFrontiers
Tracking ADHD Over Time in the MTA Study
- James Swanson, PhD
advertisement
Untangling ADHD and Co-Occurring Conditions
NeuroFrontiers
Untangling ADHD and Co-Occurring Conditions
- Roberto Olivardia, PhD
Multidisciplinary Coordination in TK2d Diagnosis and Management
NeuroFrontiers
Multidisciplinary Coordination in TK2d Diagnosis and Management
- Charles Turck, PharmD, BCPS, BCCCP
- Zarazuela Zolkipli-Cunningham, MBChB, MRCP
- Oscar H. (Hank) Mayer, MD
Insights on Migraine Care Disparities from OVERCOME
AudioAbstracts
Insights on Migraine Care Disparities from OVERCOME
- Ryan Quigley
Measuring Migraine: The Potential of CGRP
NeuroFrontiers
Measuring Migraine: The Potential of CGRP
- Shradha Kakde, MBBS
Vagus Nerve Stimulation Shows Short-Term Benefit in Chronic Migraine Trial
NeuroFrontiers
Vagus Nerve Stimulation Shows Short-Term Benefit in Chronic Migraine Trial
Understanding Disparities in Migraine Diagnosis: Evidence from Real-World Data
NeuroFrontiers
Understanding Disparities in Migraine Diagnosis: Evidence from Real-World Data
- Juliana VanderPluym, MD
advertisement
Rethinking Vestibular Migraine in Clinical Practice
NeuroFrontiers
Rethinking Vestibular Migraine in Clinical Practice
Improving Migraine Diagnosis in Vulnerable Populations
NeuroFrontiers
Improving Migraine Diagnosis in Vulnerable Populations
- Juliana VanderPluym, MD
The Role of CGRPs in First-Line Preventive Migraine Therapy
NeuroFrontiers
The Role of CGRPs in First-Line Preventive Migraine Therapy
- Charles Turck, PharmD, BCPS, BCCCP
- Richard B. Lipton, MD
- Hope O'Brien, MD, MBA, FAHS, FAAN